Our top pick for
China Rapid Finance Limited is a credit services business based in the US. China Rapid Finance shares (XRF) are listed on the NYSE and all prices are listed in US Dollars. China Rapid Finance employs 163 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$0.00 - $0.00|
|50-day moving average||$2.06|
|200-day moving average||$2.00|
|Wall St. target price||$1.20|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.86|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing China Rapid Finance stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of China Rapid Finance's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
China Rapid Finance's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. In other words, China Rapid Finance shares trade at around 2x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Revenue TTM||$46.7 million|
|Gross profit TTM||$40.2 million|
|Return on assets TTM||-15.75%|
|Return on equity TTM||0%|
|Market capitalisation||$41.3 million|
TTM: trailing 12 months
There are currently 55,202 China Rapid Finance shares held short by investors – that's known as China Rapid Finance's "short interest". This figure is 31.8% up from 41,870 last month.
There are a few different ways that this level of interest in shorting China Rapid Finance shares can be evaluated.
China Rapid Finance's "short interest ratio" (SIR) is the quantity of China Rapid Finance shares currently shorted divided by the average quantity of China Rapid Finance shares traded daily (recently around 1.1 million). China Rapid Finance's SIR currently stands at 0.05. In other words for every 100,000 China Rapid Finance shares traded daily on the market, roughly 50 shares are currently held short.
However China Rapid Finance's short interest can also be evaluated against the total number of China Rapid Finance shares, or, against the total number of tradable China Rapid Finance shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case China Rapid Finance's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 China Rapid Finance shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable China Rapid Finance shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against China Rapid Finance.
Find out more about how you can short China Rapid Finance stock.
We're not expecting China Rapid Finance to pay a dividend over the next 12 months.
China Rapid Finance's shares were split on a 1:10 basis on 2 December 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your China Rapid Finance shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for China Rapid Finance shares which in turn could have impacted China Rapid Finance's share price.
Over the last 12 months, China Rapid Finance's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while China Rapid Finance's is 0.7206. This would suggest that China Rapid Finance's shares are less volatile than average (for this exchange).
SOS Limited, through its subsidiaries, offers fin-tech and emergency rescue services. Its fin-tech business offers decisioning technology and marketing services for consumer credit market. The company also provides a range of emergency rescue services to its corporate and individual members. It also offers various types of membership cards to individual members in large corporations, such as SOS medical rescue card, SOS auto rescue card, SOS financial rescue card, and SOS life rescue card. The company was formerly known as China Rapid Finance Limited and changed its name to SOS Limited in July 2020. SOS Limited was founded in 2004 and is headquartered in Shandong, the People's Republic of China. .
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Oct. 22, 2021
Everything we know about the Trump Media and Technology Group IPO, plus information on how to buy in.
Steps to owning and managing Valkyrie Bitcoin Strategy ETF units.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.